ID   TFPI1_RAT               Reviewed;         302 AA.
AC   Q02445;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   24-JUL-2024, entry version 166.
DE   RecName: Full=Tissue factor pathway inhibitor;
DE            Short=TFPI;
DE   AltName: Full=Extrinsic pathway inhibitor;
DE            Short=EPI;
DE   AltName: Full=Lipoprotein-associated coagulation inhibitor;
DE            Short=LACI;
DE   Flags: Precursor;
GN   Name=Tfpi;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=1639767; DOI=10.1093/oxfordjournals.jbchem.a123818;
RA   Enjyoji K., Emi M., Mukai T., Kato H.;
RT   "cDNA cloning and expression of rat tissue factor pathway inhibitor
RT   (TFPI).";
RL   J. Biochem. 111:681-687(1992).
CC   -!- FUNCTION: Inhibits factor X (X(a)) directly and, in a Xa-dependent way,
CC       inhibits VIIa/tissue factor activity, presumably by forming a
CC       quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic
CC       action and also the ability to associate with lipoproteins in plasma
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Most abundant in heart, lung, kidney, and aortic
CC       endothelial cells.
CC   -!- DOMAIN: This inhibitor contains three inhibitory domains. The first
CC       domain interacts with VIIa and TF, the second one with Xa (By
CC       similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D10926; BAA01724.1; -; mRNA.
DR   PIR; JX0213; TIRTGK.
DR   RefSeq; NP_058896.1; NM_017200.1.
DR   RefSeq; XP_006234502.1; XM_006234440.3.
DR   RefSeq; XP_006234503.1; XM_006234441.2.
DR   RefSeq; XP_006234506.1; XM_006234444.2.
DR   AlphaFoldDB; Q02445; -.
DR   SMR; Q02445; -.
DR   BioGRID; 248083; 1.
DR   STRING; 10116.ENSRNOP00000006787; -.
DR   MEROPS; I02.011; -.
DR   MEROPS; I02.012; -.
DR   MEROPS; I02.950; -.
DR   GlyCosmos; Q02445; 3 sites, No reported glycans.
DR   GlyGen; Q02445; 3 sites.
DR   PhosphoSitePlus; Q02445; -.
DR   PaxDb; 10116-ENSRNOP00000006787; -.
DR   Ensembl; ENSRNOT00000100291.1; ENSRNOP00000078992.1; ENSRNOG00000005039.9.
DR   Ensembl; ENSRNOT00065036723; ENSRNOP00065029561; ENSRNOG00065021597.
DR   GeneID; 29436; -.
DR   KEGG; rno:29436; -.
DR   UCSC; RGD:61914; rat.
DR   AGR; RGD:61914; -.
DR   CTD; 7035; -.
DR   RGD; 61914; Tfpi.
DR   eggNOG; KOG4295; Eukaryota.
DR   GeneTree; ENSGT00940000160767; -.
DR   HOGENOM; CLU_058441_2_0_1; -.
DR   InParanoid; Q02445; -.
DR   OMA; WWILCAV; -.
DR   OrthoDB; 3558236at2759; -.
DR   PhylomeDB; Q02445; -.
DR   TreeFam; TF315349; -.
DR   Reactome; R-RNO-140834; Extrinsic Pathway of Fibrin Clot Formation.
DR   PRO; PR:Q02445; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000005039; Expressed in ovary and 20 other cell types or tissues.
DR   ExpressionAtlas; Q02445; baseline and differential.
DR   GO; GO:0005901; C:caveola; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:GO_Central.
DR   GO; GO:0007596; P:blood coagulation; IEA:UniProtKB-KW.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; ISO:RGD.
DR   GO; GO:0030195; P:negative regulation of blood coagulation; ISO:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   CDD; cd22613; Kunitz_TFPI1_1-like; 1.
DR   CDD; cd22614; Kunitz_TFPI1_2-like; 1.
DR   CDD; cd22615; Kunitz_TFPI1_TFPI2_3-like; 1.
DR   Gene3D; 4.10.410.10; Pancreatic trypsin inhibitor Kunitz domain; 3.
DR   InterPro; IPR050098; Kunitz-type_SerProtInhib.
DR   InterPro; IPR002223; Kunitz_BPTI.
DR   InterPro; IPR036880; Kunitz_BPTI_sf.
DR   InterPro; IPR020901; Prtase_inh_Kunz-CS.
DR   InterPro; IPR008296; TFPI-like.
DR   PANTHER; PTHR10083; KUNITZ-TYPE PROTEASE INHIBITOR-RELATED; 1.
DR   PANTHER; PTHR10083:SF328; TISSUE FACTOR PATHWAY INHIBITOR; 1.
DR   Pfam; PF00014; Kunitz_BPTI; 3.
DR   PIRSF; PIRSF001620; TFPI; 1.
DR   PRINTS; PR00759; BASICPTASE.
DR   SMART; SM00131; KU; 3.
DR   SUPFAM; SSF57362; BPTI-like; 3.
DR   PROSITE; PS00280; BPTI_KUNITZ_1; 3.
DR   PROSITE; PS50279; BPTI_KUNITZ_2; 3.
PE   2: Evidence at transcript level;
KW   Blood coagulation; Disulfide bond; Glycoprotein; Hemostasis;
KW   Protease inhibitor; Reference proteome; Repeat; Secreted;
KW   Serine protease inhibitor; Signal.
FT   SIGNAL          1..28
FT   CHAIN           29..302
FT                   /note="Tissue factor pathway inhibitor"
FT                   /id="PRO_0000016875"
FT   DOMAIN          53..103
FT                   /note="BPTI/Kunitz inhibitor 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DOMAIN          124..174
FT                   /note="BPTI/Kunitz inhibitor 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DOMAIN          222..272
FT                   /note="BPTI/Kunitz inhibitor 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   SITE            63..64
FT                   /note="Reactive bond"
FT                   /evidence="ECO:0000250"
FT   SITE            134..135
FT                   /note="Reactive bond"
FT                   /evidence="ECO:0000250"
FT   SITE            232..233
FT                   /note="Reactive bond"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        144
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        251
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        261
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        53..103
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DISULFID        62..86
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DISULFID        78..99
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DISULFID        124..174
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DISULFID        133..157
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DISULFID        149..170
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DISULFID        222..272
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DISULFID        231..255
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DISULFID        247..268
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
SQ   SEQUENCE   302 AA;  34554 MW;  F9AE82130A24A59F CRC64;
     MTNKLKKDHA FWAAVCLLLS IVPELLNALP EEDDDTINTD SELRPMKPLH TFCAMKAEDG
     PCKAMIRSYY FNMNSHQCEE FIYGGCRGNK NRFDTLEECR KTCIPGYKKT TIKTTSGAEK
     PDFCFLEEDP GICRGFMTRY FYNNQSKQCE QFKYGGCLGN SNNFETLEEC RNTCEDPVNE
     VQKGDYVTNQ ITVTDRTTVN NVVIPQATKA PSQWDYDGPS WCLEPADSGL CKASEKRFYY
     NPAIGKCRQF NYTGCGGNNN NFTTKQDCNR ACKKDSSKKS SKRAKTQRRR KSFVKVMYEN
     IH
//
